| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/21/2002 | US20020035062 Process for the preparation of a protein solution |
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020035060 Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer |
| 03/21/2002 | US20020035056 54420, a novel human calcium channel |
| 03/21/2002 | US20020035046 Suitable for use in skin care applications, which effectively deliver and/or deposit various benefit agents into and onto the skin and which are relatively non-irritating |
| 03/21/2002 | US20020034821 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 03/21/2002 | US20020034813 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging |
| 03/21/2002 | US20020034812 Caspase homologue |
| 03/21/2002 | US20020034809 Process for producing a plasma protein-containing medicament |
| 03/21/2002 | US20020034807 Nucleotide sequences coding enzymatic proteins; for use in the treatment of cell proliferation and differention disorders; antiproliferative agents |
| 03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 03/21/2002 | US20020034804 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agent |
| 03/21/2002 | US20020034800 Preferential bone marrow polypeptides; for generation of erythrocytes; for healing fractured bones |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034785 Nucleotide sequences coding preferential binding protein for use in the treatment of bacterial, fungal, protozoan and viral infections; pain; cancers; eating, nervous system, psychological and cardiovascular disorders |
| 03/21/2002 | US20020034784 Novel molecules of the card-related protein family and uses thereof |
| 03/21/2002 | US20020034783 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of tumors; antitumor agents |
| 03/21/2002 | US20020034781 Nucleotide sequences coding membrane protein for use in treatment and diagnosis of pain defects |
| 03/21/2002 | US20020034780 Novel human protein kinases and uses therefor |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
| 03/21/2002 | US20020034768 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 03/21/2002 | US20020034764 Diarylsulfonylurea binding proteins |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034755 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/21/2002 | US20020034741 Utilization of preferential peptide for the treatment of wounds and gastrointestinal disorders; wound healing agents |
| 03/21/2002 | US20020034738 Human vascular ibp-like growth factor |
| 03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
| 03/21/2002 | US20020034734 Vaccine composition for preventing or treating hepatitis C |
| 03/21/2002 | US20020034726 Modulators for amplifying chemotaxis; for use in the treatment of allergic defects; for use in treatment of tumors |
| 03/21/2002 | US20020034725 Sensitization of cells to radiation and and chemotherapy |
| 03/21/2002 | US20020034532 Injectable depot gel composition and method of preparing the composition |
| 03/21/2002 | US20020034531 Demineralized bone powder and carrier comprising liquid poloxamer solution or solid poloxamer dissolved in solvent, whereby carrier achieves reverse phase characteristics when mixed with demineralized bone powder |
| 03/21/2002 | US20020034517 Dendritic cell stimulatory factor |
| 03/21/2002 | US20020034516 Test kits; genetic engineering |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034510 Genetic engineered protein; antiischemic agents |
| 03/21/2002 | US20020034509 Methods and compositions for ameliorating the symptoms of sepsis |
| 03/21/2002 | US20020034507 Inhibitor of lymphocyte activation |
| 03/21/2002 | US20020034506 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/21/2002 | US20020034501 Methods and compositions for promoting angiogenesis using monocytes |
| 03/21/2002 | US20020034500 Regulatory T cells; methods |
| 03/21/2002 | US20020034499 Nutrient medium which can be used as a culture medium for epidermal cells and applications |
| 03/21/2002 | US20020034495 Gene therapy |
| 03/21/2002 | US20020034494 Fusion protein of chemokine and antigens |
| 03/21/2002 | US20020034488 Using oxidizing enzymes and maleic anhydride, alkyl vinyl ether copolymer |
| 03/21/2002 | US20020034477 Dry powder; complex |
| 03/21/2002 | US20020033181 Treatment of hepatitis C using hyperthermia |
| 03/21/2002 | DE10045047A1 Arzneimittel enthaltend aktiviertes Antithrombin III Medicines containing activated antithrombin III |
| 03/21/2002 | DE10044325A1 Neue MMP-2-Derivate als Inhibitoren des Integrins avbeta3 New MMP-2 derivatives as inhibitors of the integrin avbeta3 |
| 03/21/2002 | DE10043674A1 New antisense oligonucleotides and ribozymes, useful for treating e.g. pain and for diagnosis, are directed against mRNA for vanilloid-family receptors |
| 03/21/2002 | DE10033195A1 Bifunktionale Fusionsproteine aus Hirudin und TAP Bifunctional fusion proteins of hirudin and TAP |
| 03/21/2002 | CA2459599A1 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | CA2423559A1 22 human secreted proteins |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422814A1 Cripto mutant and uses thereof |
| 03/21/2002 | CA2422774A1 Remedies for amyotrophic lateral sclerosis |
| 03/21/2002 | CA2422603A1 Vectors for molecule delivery to cd11b expressing cells |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/21/2002 | CA2422288A1 Novel mammalian receptor genes and uses |
| 03/21/2002 | CA2422275A1 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422095A1 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | CA2422076A1 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 03/21/2002 | CA2422068A1 Method for treatment of insulin resistance in obesity and diabetes |
| 03/21/2002 | CA2422060A1 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2422033A1 Method for treating inflammation |
| 03/21/2002 | CA2422032A1 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | CA2422026A1 Reduction of the electrocardiographic qt interval for reducing the risk of sudden death |
| 03/21/2002 | CA2421994A1 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | CA2421966A1 Remedies for ischemic diseases |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421949A1 Novel nucleic acids and polypeptides |
| 03/21/2002 | CA2421786A1 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 03/21/2002 | CA2421751A1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | CA2421585A1 Method and composition for treating tumors by selective induction of apoptosis |
| 03/21/2002 | CA2421303A1 Novel compounds |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420932A1 Novel mammalian nuclear receptor l66 and methods of use |
| 03/21/2002 | CA2420892A1 Human coagulation factor vii variants |
| 03/21/2002 | CA2420504A1 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/20/2002 | EP1188832A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/20/2002 | EP1188831A2 Target of RNAIII activating protein (TRAP) |
| 03/20/2002 | EP1188830A1 Novel hemopoietin receptor protein nr10 |
| 03/20/2002 | EP1188828A1 Reg-binding protein |
| 03/20/2002 | EP1188824A2 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 03/20/2002 | EP1188768A2 LHRH antagonist peptides |
| 03/20/2002 | EP1188766A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/20/2002 | EP1188765A1 Mechanism oriented inhibitors of dipeptidyl peptidase I |
| 03/20/2002 | EP1188448A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1188445A1 Drug composition containing lecithin-modified superoxide dismutase |
| 03/20/2002 | EP1188444A1 FSH and FSH variant formulations, products and methods |
| 03/20/2002 | EP1188443A1 Improved protocol for paracentesis |